New UK facility to turbo-charge development of novel RNA therapies
By 
Julia Robinson2025-09-05T08:30:00
Government to invest £30 million in RNA biofoundry to accelerate therapies for cancer and genetic disorders
The UK government is investing almost £30 million to establish a specialised facility to support the development of new RNA therapies, it has been announced.
The UK RNA Biofoundry, which will be based at CPI’s RNA Centre of Excellence in Darlington, will give UK scientists and businesses working in the field the necessary tools to progress their ideas and speed up the rate that new RNA therapies get to market and into the hands of patients.